Covered recipient · General Payments record
ANJAN JAYANTILAL PATEL
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2019–2025
$13,269.77
- Reported across 164 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,980.00 | 1 |
| Food and Beverage | $1,269.63 | 45 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $78.95 | 1 |
| Education | $53.45 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Global Services, LLC | $1,980.00 | 1 |
| Janssen Biotech, Inc. | $233.89 | 5 |
| ARRAY BIOPHARMA INC | $171.20 | 5 |
| Alexion Pharmaceuticals, Inc. | $121.84 | 1 |
| Celltrion USA Inc. | $115.04 | 1 |
| Astellas Pharma US Inc | $90.80 | 5 |
| E.R. Squibb & Sons, L.L.C. | $83.54 | 4 |
| TerSera Therapeutics LLC | $79.01 | 2 |
| Acerta Pharma LLC | $68.33 | 3 |
| PFIZER INC. | $65.73 | 4 |
| GlaxoSmithKline, LLC. | $57.01 | 3 |
| Genentech, Inc. | $53.45 | 1 |
| Celgene Corporation | $43.04 | 2 |
| TAIHO ONCOLOGY, INC. | $32.42 | 2 |
| Sumitomo Pharma America, Inc. | $31.31 | 2 |
| Merck Sharp & Dohme Corporation | $27.89 | 1 |
| Myriad Genetic Laboratories, Inc. | $26.99 | 1 |
| Ipsen Biopharmaceuticals, Inc | $26.85 | 1 |
| Napo Pharmaceuticals Inc | $24.28 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.86 | 1 |
| Deciphera Pharmaceuticals Inc. | $17.48 | 1 |
| ABBVIE INC. | $14.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (48)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.